ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 104 filers reported holding ORAMED PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,374,000 | +64.4% | 366,401 | +16.2% | 2.07% | +38.0% |
| Q2 2022 | $1,444,000 | -42.5% | 315,301 | +8.5% | 1.50% | -18.1% |
| Q1 2022 | $2,513,000 | -18.3% | 290,501 | +34.9% | 1.83% | -3.2% |
| Q4 2021 | $3,076,000 | -34.6% | 215,401 | +0.7% | 1.89% | -39.1% |
| Q3 2021 | $4,702,000 | +9.0% | 213,901 | -33.6% | 3.10% | +9.5% |
| Q2 2021 | $4,312,000 | +11.7% | 322,249 | -15.2% | 2.83% | +4.8% |
| Q1 2021 | $3,860,000 | +57.7% | 379,944 | -34.2% | 2.70% | +38.7% |
| Q4 2020 | $2,448,000 | +62.8% | 577,317 | +0.2% | 1.95% | +29.9% |
| Q3 2020 | $1,504,000 | +3.2% | 576,317 | +39.6% | 1.50% | -5.2% |
| Q2 2020 | $1,458,000 | +1403.1% | 412,893 | +1194.3% | 1.58% | +1156.3% |
| Q1 2020 | $97,000 | -39.0% | 31,900 | +3.2% | 0.13% | -19.2% |
| Q4 2019 | $159,000 | – | 30,900 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Acrospire Investment Management LLC | 8,355 | $61,000 | 0.04% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 70,000 | $508,000 | 0.01% |
| Financial Architects, Inc | 2,000 | $15,000 | 0.00% |
| FineMark National Bank & Trust | 3,473 | $25,000 | 0.00% |
| JFS WEALTH ADVISORS, LLC | 1,000 | $7,000 | 0.00% |
| Penserra Capital Management LLC | 2,540 | $18,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,284 | $10,000 | 0.00% |
| SIMPLEX TRADING, LLC | 2,673 | $19,000 | 0.00% |
| Plante Moran Financial Advisors, LLC | 300 | $2,000 | 0.00% |
| Cutler Group LLC / CA | 2,404 | $17,000 | 0.00% |